Matthew Schuelke

4PUBLICATIONS
17CO-AUTHORS
Adolescent healthMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 18, 2023
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.

Matthew R Schuelke, Hamid Bassiri, Edward M Behrens

|Mar 27, 2021
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.

Timothy Kottke, Jason Tonne, Laura Evgin

|Jun 26, 2020
Oncolytic virus-derived type I interferon restricts CAR T cell therapy.

Laura Evgin, Amanda L Huff, Phonphimon Wongthida

|Feb 09, 2020
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.

Christopher B Driscoll, Matthew R Schuelke, Timothy Kottke

Pageof 1

Frequent Collaborators

2 joint publications

Richard Vile

1 joint publications

Reuben Harris

1 joint publications

Christopher B Driscoll

1 joint publications

Jacob van Vloten